Disease timing
Ask what remission or response is expected before transplant and how the hospital manages an urgent or relapsed disease.
Allogeneic stem cell transplant in India
Best Hospitals for Allogeneic Stem Cell Transplant in India
A detailed route for comparing donor-cell programmes, HLA and donor search, conditioning, cellular therapy laboratories, GVHD care, ICU support, and long-term follow-up.
What makes an allogeneic transplant programme suitable?
The programme should demonstrate a clear donor and HLA pathway, controlled cell collection and processing, infection and transfusion systems, graft-versus-host expertise, critical care, and a long-term plan for both patient and donor where applicable.
Share your treatment records
Get a hospital shortlist matched to the patient’s case.
A report-led review helps the care team compare procedure fit, hospital capability, city, timing, and travel needs before an enquiry is sent.
Official email: support@virellohealth.com
Let Us Help You
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Shortlist decision
How to choose the right hospital path
Donor search
Compare HLA typing, related and unrelated donor options, haploidentical pathways, cord sources, and search timelines.
Cell handling
Confirm collection, processing, storage, labeling, traceability, transport, and release procedures for donor cells.
GVHD expertise
Ask how the programme prevents, diagnoses, and treats acute and chronic graft-versus-host disease.
Infection and ICU
Check isolation, viral monitoring, antimicrobial medicines, transfusion, ICU, ventilation, dialysis, and emergency access.
Family and donor support
A complete plan includes donor counselling, caregiver accommodation, language help, and follow-up after returning home.
Hospitals patients often compare
Use hospital names as a starting point, then verify case fit.
The examples below are not a fixed ranking. They show how families can discuss hospital types, city routes, and department strengths before a report-led shortlist is prepared.
Bengaluru
Ramaiah Memorial Hospital
FACT-listed adult and pediatric allogeneic and autologous hematopoietic progenitor cell programme.
Its public accreditation record offers a useful starting point for checking donor-cell programme scope.
Verify current accreditation date, donor pathway, patient age, processing services, and admission capacity.
Evidence check
Campus reviewed: Ramaiah Memorial Hospital, Bengaluru. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Kolkata
Tata Medical Center
Cancer-focused programme with adult and pediatric allogeneic cellular therapy listed by FACT.
It may be relevant for complex leukemia, lymphoma, pediatric, or other hematologic indications.
Ask which donor sources are available, what reports are required, and how urgent admissions are handled.
Evidence check
Campus reviewed: Tata Medical Center, Kolkata. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
New Delhi
BLK-Max Super Speciality Hospital
Private BMT pathway with hematology, donor evaluation, cell processing, protective care, transfusion, and ICU support.
New Delhi offers a private route with broad oncology and critical-care services.
Confirm allogeneic programme scope, HLA laboratory, unrelated donor coordination, and GVHD follow-up.
Evidence check
Campus reviewed: BLK-Max Super Speciality Hospital, New Delhi. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Gurugram
Medanta - The Medicity
Multispecialty transplant centre with hematology, donor search, laboratory, ICU, infectious disease, and organ support.
A multispecialty campus may help when transplant risk is increased by organ or infection concerns.
Request donor-to-recipient timeline, cell-processing pathway, ICU backup, and home follow-up plan.
Evidence check
Campus reviewed: Medanta - The Medicity, Gurugram. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Chennai
Apollo Cancer Centre
Private oncology and transplant pathway with hematology, HLA workup, cell handling, transfusion, and supportive care.
Chennai can be practical for international families planning a prolonged treatment episode.
Ask whether donor testing, collection, conditioning, and post-transplant review happen on the same campus.
Evidence check
Campus reviewed: Apollo Cancer Centre, Chennai. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Bengaluru
HCG Cancer Centre
Cancer network with hematology, allogeneic transplant evaluation, laboratory, infection, and supportive services.
Bengaluru gives families another private route to compare with documented or hospital-confirmed programme details.
Verify the exact branch, donor scope, pediatric care, ICU, and graft-versus-host clinic.
Evidence check
Campus reviewed: HCG Cancer Centre, Bengaluru. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Vellore
CMC Vellore
Academic route with hematology, pediatric and adult care, laboratory, transplant, and complex medical support.
An academic setting may be useful for difficult donor, relapse, or pediatric transplant decisions.
Check referral requirements, donor testing, availability, and expected admission wait.
Evidence check
Campus reviewed: CMC Vellore, Vellore. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Kochi
Aster Medcity
Tertiary hospital option with hematology, transplant assessment, infection, intensive care, and recovery support.
Kochi may suit selected stable treatment or follow-up when allogeneic services are confirmed.
Verify current cell processing, donor arrangements, GVHD care, and urgent review pathway.
Evidence check
Campus reviewed: Aster Medcity, Kochi. Source review: 2026-08-01.
Availability and credentials can change. Confirm the exact programme, treating team, and current case acceptance before booking.
Cancer-specific care pathway
How the team moves from diagnosis to follow-up
The right hospital should be able to coordinate the tests, pathology review, treatment decisions, and recovery support that match this cancer type and the patient’s current condition.
Allogeneic transplant diagnosis and eligibility
The team must confirm the disease, response, and fitness while explaining why donor-cell treatment is being considered.
Disease and response
Marrow, flow, molecular, pathology, imaging, and MRD results may determine whether the patient is ready for transplant.
Fitness review
Heart, lung, kidney, liver, infection, dental, nutrition, fertility, and psychosocial assessments help identify risks.
Donor workup
Potential donors need HLA testing, medical assessment, informed consent, collection discussion, and independent support.
Alternatives and timing
The team should explain other consolidation or medicine routes, donor search time, relapse risk, and urgency.
Donor and transplant risk assessment
Allogeneic risk includes disease risk, donor relationship and match, conditioning, immune complications, and patient fitness.
HLA and donor type
The programme explains matched related, matched unrelated, haploidentical, or cord blood options and their trade-offs.
Disease status
Remission depth, MRD, relapse, genetic risk, prior treatment, and active infection affect transplant timing and outcomes.
GVHD and relapse risk
The team discusses immune complications, disease control, graft failure, relapse, and medicines used to reduce risk.
Donor safety
Living donors need medical and psychosocial evaluation, informed consent, collection risk review, and follow-up.
Allogeneic transplant treatment plan
The treatment plan should make the donor, cell, conditioning, infusion, and immune-recovery steps understandable.
Donor collection
Cells may be collected from peripheral blood, marrow, or another approved source with documented identity and traceability.
Conditioning
Chemotherapy with or without radiation prepares the patient and is selected according to disease, donor, age, and fitness.
Infusion and engraftment
Donor cells are infused through a central line, then blood counts, chimerism, fever, organ function, and graft recovery are monitored.
GVHD and infection prevention
Immune suppression, antimicrobial prophylaxis, viral monitoring, transfusion, and prompt treatment of complications are essential.
Allogeneic transplant follow-up
Follow-up includes disease surveillance, immune recovery, graft-versus-host review, and care for donor and recipient needs.
Chimerism and disease checks
Blood, marrow, MRD, chimerism, molecular tests, or imaging are scheduled according to diagnosis and response.
GVHD surveillance
Skin, mouth, eyes, gut, liver, lungs, joints, and nutrition may need repeated assessment for acute or chronic GVHD.
Immune recovery
Vaccines, infection prevention, antimicrobial medicines, blood products, and return-to-work or school guidance are reviewed.
Home coordination
The recipient and donor should receive separate follow-up instructions, emergency contacts, and a route for remote review.
Selection criteria
What to compare before choosing a hospital
Donor pathway
Can the hospital perform HLA testing and coordinate related, unrelated, haploidentical, or cord sources?
Ask which registry or partner handles search.
Programme evidence
Is current authorization or cellular-therapy accreditation available for the planned type and age group?
Check the exact campus scope.
GVHD service
Is there a dedicated process for prevention, diagnosis, treatment, and long-term chronic GVHD?
Ask who reviews patients after discharge.
Infection and ICU
Can the centre manage viral reactivation, fungal infection, sepsis, ventilation, dialysis, and transfusion?
Confirm 24-hour emergency access.
Donor protection
Does the donor receive independent consent, medical and psychosocial assessment, and follow-up?
Donor care must not be treated as an afterthought.
Continuity
Will the hospital issue a transplant summary, vaccine plan, laboratory schedule, and local handover?
This is essential after international travel.
Treatment fit
Match hospital strength to the treatment pathway
The same hospital can be strong in several areas, but each patient still needs matching by diagnosis, procedure, risk, and recovery needs.
Donor and laboratory pathway
The programme should be transparent about the donor search and cell journey.
Matching and collection
Ask how HLA, donor consent, collection, transport, product identity, and backup plans are managed.
Processing controls
Confirm where cells are processed, how they are released, and how traceability is maintained.
Immune recovery and survivorship
Allogeneic care continues well after engraftment.
GVHD management
Compare specialist access for skin, gut, liver, lung, eye, mouth, joint, and nutritional complications.
Long-term review
Ask about relapse, chimerism, vaccines, fertility, bone, endocrine, heart, lung, and psychological follow-up.
City strategy
Compare Tier 1 depth with Tier 2 value
Bengaluru and Kolkata
Provide cellular therapy programmes whose current scope can be checked in public accreditation listings.
Confirm patient age and donor type.
Delhi NCR
Offers private and academic transplant routes with broad critical care.
Compare donor search, GVHD, and accommodation logistics.
Chennai
Provides a major private oncology and transplant ecosystem.
Ask for the full donor-to-discharge calendar.
Hyderabad and Kochi
May suit planned transplant when authorization, cell processing, and emergency services are confirmed.
Verify exact campus capacity.
Vellore and other cities
Academic routes can be useful for complex review or second opinion.
Do not select without checking wait times and donor arrangements.
Reports before matching
What to share before asking for a shortlist
Reports help the hospital and doctor team understand whether the patient needs a complex metro route, a specialty center, or a stable planned-care option.
- 1 Diagnosis, marrow, flow, cytogenetic, molecular, MRD, imaging, and prior response records.
- 2 HLA results, donor relationship, donor testing, registry search, collection, and consent records.
- 3 Conditioning, transfusion, infection, ICU, GVHD, discharge, and previous transplant treatment documents.
- 4 Heart, lung, kidney, liver, dental, fertility, nutrition, vaccination, and medication assessments.
- 5 Current fever, rash, diarrhea, breathing, bleeding, line, or infection history.
- 6 Recipient and donor identity documents, caregiver details, and preferred language for consent and safety teaching.
Cost and stay planning
What can change total treatment cost
Donor search and testing
HLA, donor medical workup, registry search, collection, travel, and related documentation can affect cost and timing.
Ask who pays each donor-side cost.
Conditioning and admission
Regimen, isolation, transfusion, infection, ICU, medicines, and engraftment determine the inpatient estimate.
Request a complication contingency.
Cell processing
Collection, transport, processing, storage, release, and traceability may be billed separately.
Confirm whether the process is in-house.
GVHD and immune care
Immunosuppression, antimicrobial medicines, laboratory monitoring, and repeated reviews can continue after discharge.
Ask for a monthly follow-up estimate.
Recipient and donor stay
Both people may need accommodation, transport, food planning, and separate follow-up arrangements.
Plan the donor and recipient journeys together.
International patient support
Support that should be planned with hospital choice
Donor coordination
Help can organize HLA records, donor documentation, appointment sequence, consent, and travel requirements.
Recipient calendar
The family should see donor search, conditioning, infusion, engraftment, discharge, and early follow-up dates.
Infection-safe stay
Plan nearby lodging, food precautions, visitor rules, transport, and rapid access to the hospital.
GVHD education
Families should learn how to recognize rash, diarrhea, jaundice, dry eyes, mouth changes, breathing symptoms, and fever.
Language assistance
Interpreter support should cover donor consent, conditioning, immune suppression, infection, and emergency guidance.
Long-term handover
The recipient and donor should each leave with separate summaries, medicines, tests, and follow-up contacts.
Safety checks
Red flags to review before booking travel
No donor verification
A hospital should not promise donor availability or transplant timing before HLA and authorization checks.
GVHD omitted
A transplant explanation that ignores graft-versus-host disease and long-term immune care is incomplete.
Emergency symptoms
Fever, rash, diarrhea, jaundice, breathlessness, bleeding, or confusion needs urgent transplant-team review.
Commercial pressure
Consent, donor choice, and transplant decisions must remain voluntary, informed, ethical, and free from coercion.
Sources and review
Check the evidence behind this guide
Hospital availability, accreditation, authorization, and treatment claims can change. Confirm the current campus details with the hospital before travel or admission.
FACT India cellular therapy directory FACT cellular therapy standards WHO transplantation principles National Cancer Grid
Allogeneic pathway reviewed for page planning on 30 July 2026. Donor availability, authorization, accreditation scope, prices, and current programme capacity require confirmation.
Questions
Common questions
What is allogeneic stem cell transplant?
It is a transplant in which hematopoietic stem cells come from a donor. The pathway includes HLA and donor assessment, conditioning, infusion, engraftment, immune suppression, and long-term monitoring.
How is a donor found for allogeneic transplant?
The team may assess related, unrelated, haploidentical, or cord sources using HLA and other clinical factors. Donor availability and timing cannot be guaranteed.
What is graft-versus-host disease?
It is an immune complication in which donor immune cells react against recipient tissues. The transplant team explains prevention, warning signs, treatment, and long-term monitoring.
How long does allogeneic transplant recovery take?
Engraftment can take weeks, while immune recovery, infection precautions, immunosuppression, and GVHD monitoring may continue for months or years.
What authorization should I check in India?
Check the current official hospital or transplant authorization relevant to the service and any applicable cellular-therapy accreditation and scope.
Can international donors travel to India?
Donor travel depends on legal, medical, consent, identity, visa, and hospital requirements. The transplant coordinator must confirm the process.
What happens after the patient returns home?
The patient needs blood or marrow monitoring, infection and GVHD review, medicine management, vaccines, and a clear route back to the transplant team.
Can Virello Health arrange an allogeneic transplant enquiry?
Virello Health can organize records and verified hospital communication, while the transplant team decides eligibility, donor route, and treatment.
Continue planning
Move from hospital research to a report-led shortlist
Bone marrow transplant hospitals
Review the wider BMT comparison.
Autologous transplant hospitals
Compare patient-cell transplant.
Leukemia treatment hospitals
Review blood cancer pathways.
Allogeneic transplant cost
Understand donor and admission costs.
Hematology doctors
Request a transplant review.
Upload donor records
Share HLA and treatment documents.
Second opinion
Ask for another transplant opinion.
Hospitals by procedure
Compare other hospital guides.
Patient services
Plan donor and recipient support.